Cerity Partners’s Alpha Tau Medical DRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$513K Buy
40,809
+8,797
+27% +$79.9K ﹤0.01% 2407
2026
Q1
$226K Buy
+32,012
New +$226K ﹤0.01% 2807

Other funds holding DRTS

Cerity Partners's DRTS Position: Q2 2026 in Review

Cerity Partners increased its Alpha Tau Medical (DRTS) stake by 27% in Q2 2026, buying an estimated $79.9K and bringing the position to 40,809 shares worth $513K. The position accounts for ﹤0.01% of the portfolio, ranked #2407.

Cerity Partners first reported a position in DRTS in Q1 2026 and has held it in 2 quarters since. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

  • Cerity Partners held 40,809 shares of Alpha Tau Medical worth $513K as of Q2 2026.
  • Cerity Partners bought 8,797 Alpha Tau Medical shares in Q2 2026, an estimated $79.9K.
  • Alpha Tau Medical made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2407 holding.
  • Cerity Partners first reported a position in Alpha Tau Medical in Q1 2026 and has held it in 2 quarters since.
  • 74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.